The burgeoning incidence of lifestyle-related ailments stands as a pivotal catalyst propelling the expansion of the cholesterol-testing products market. Conditions like obesity, diabetes, and hypertension, acknowledged precursors to elevated cholesterol levels and cardiovascular disorders, significantly contribute to this trend.
Asthma and COPD are affecting billions of people worldwide. COVID-19 has worsened it. These chronic diseases cannot be cured. But people require long-term respiratory care. Portable mesh nebulizers are one of the key solutions!